An orthotopic nude mouse model for evaluating pathophysiology and therapy of pancreatic cancer

Nursing

Volumn 26, Issue 4, 1996, Pages

  Hotz, Hubert G ^a   Reber, Howard A ^a   Hotz, Birgit ^a   Yu, Tina ^a   Foitzik, Thomas ^b   Buhr, Heinz J ^b   Cortina, Galen ^a   Hines, O Joe ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Ductal; Model; Nude mouse; Orthotopic; Pancreatic cancer; Xenograph

Indexed keywords

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL DIVISION; DISEASE MODEL; HUMAN; MALE; METHODOLOGY; MOUSE; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; PATHOPHYSIOLOGY; TIME; XENOGRAFT;

ANIMALS; CELL DIVISION; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0142048579     PISSN: 03604039     EISSN: 15388689     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med. 1992; 326:455-465.
2. Parker SL, Long T, Bolen S, Wingo PA. Cancer statistics. CA Cancer J Clin. 1997; 47:5-27.
3. Yeo CJ, Cameron JL. Pancreatic cancer. Curr Probl Surg. 1999; 36:59-152.
4. Lillemoe KD. Palliative therapy for pancreatic cancer. Surg Oncol Clin North Am. 1998; 7:199-216.
5. Glimelius B. Chemotherapy in the treatment of cancer of the pancreas. J Hep-Bil-Panc Surg. 1999; 5:235-241.
6. Regine WF, John WJ, Mohiuddin M. Adjuvant therapy for pancreatic cancer: current status. Front Biosci. 1998; 3:E186-E192.
7. Andren-Sandberg A, Beackman PL, Andersson R. Results of adjuvant therapy in resected pancreatic cancer. Int J Pancreatol. 1997; 21:31-38.
8. Fogh J, Orfeo T, Tiso J, et al. Twenty-three new human tumor lines established in nude mice. Exp Cell Biol. 1980; 48:229-239.
9. Sordat BC, Ueyama Y, Fogh J. Metastasis of tumor xenografts in the nude mouse. In: Fogh J, Giovanella BC, eds. The nude mouse in experimental and clinical research. New York: Academic Press, 1982:95-143.
10. Fidler IJ. Critical factors in the biology of human cancer metastasis. Am Surg. 1995; 61:1065-1066.
11. Fidler IJ. The biology of human cancer metastasis. Acta Oncol. 1991; 30:669-675.
12. Hoffman RM. Orthotopic is orthodox: why are orthotopic-transplant metastatic models different from all other models? J Cell Biochem. 1994; 56:1-3.
13. Fidler IJ. Modulation of the organ microenvironment for treatment of cancer metastasis. J Natl Cancer Inst. 1995; 87:1588-1592.
14. Kubota T. Metastatic models of human cancer xenografted in the nude mouse: the importance of orthotopic transplantation. J Cell Biochem. 1994; 56:4-8.
15. Mohammad RM, Al-Katib AA, Pettit GR, et al. An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies. Clin Cancer Res. 1998; 4:887-894.
16. Marincola FM, Da Pozzo LF, Drucker BJ, Holder WD. Adoptive immunotherapy of human pancreatic cancer with lymphokine-activated killer cells and interleukin-2 in a nude mouse model. Surgery. 1990; 108:919-929.
17. Tan MH, Chu TM. Characterization of the tumorigenic and metastatic properties of a human pancreatic tumor cell line (AsPC-1) implanted orthotopically into nude mice. Tumor Biol. 1985; 6:89-98.
18. Vezeridis MP, Doremus CM, Tibbetts LM, et al. Invasion metastasis following orthotopic transplantation of human pancreatic cancer in the nude mouse. J Surg Oncol. 1989; 40:261-265.
19. An Z, Wang X, Kubota T, et al. A clinical nude mouse metastatic model for highly malignant human pancreatic cancer. Anticancer Res. 1996; 16:627-632.
20. Fu K, Guadagni F, Hoffman RM. A metastatic nude mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc Natl Acad Sci 1992; 89:5645-5649.
21. Reyes G, Villanueva A, Garcia C, et al. Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice. Cancer Res 1996; 56:5713-5719.
22. Yunis AA, Arimura GK, Russin DJ. Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase. Int J Cancer. 1977; 19:128-135.
23. Tan MH, Shimano T, Chu TM. Differential localization of human pancreatic cancer-associated antigen and carcinoembryogenic antigen in homologous pancreatic tumoral xenograft. J Natl Cancer Inst. 1981; 67:563-566.
24. Metzgar RS, Gaillard MT, Levine SJ, et al. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Cancer Res. 1982; 42:601-608.
25. Kyriazis AP, Kyriazis AA, Scarpelly DG, et al. Human pancreatic adenocarcinoma line Capan-1 in tissue culture and the nude mouse. Morphologic, biologic and biochemical characteristics. Am J Pathol. 1982; 106:250-260.
26. Ikeda Y, Ezaki M, Hayashi I, et al. Establishment and characterization of human pancreatic cancer cell lines in tissue culture and in nude mice. Jpn J Cancer Res. 1990; 81:987-993.
27. Makinen K, Loimas S, Kosma VM, et al. Azaserine-induced rat pancreas tumor model with transplantable cultured cells. Pancreas. 1998; 16:160-164.
28. Jaquet P, Stuart OA, Dalton R, et al. Effect of intraperitoneal chemotherapy and fibrinolytic therapy on tumor implantation in wound sites. J Surg Oncol 1996; 62:128-134.
29. Paik PS, Misawa T, Chiang M, et al. Abdominal incision tumor implantation following pneumoperitoneum laparoscopic procedure versus standard open incision in a syngeneic rat model. Dis Colon and Rect. 1998; 41:419-422.
30. Reid SE, Scanlon EF, Kaufman MW, Murthy MS. Role of cytokines and growth factors in promoting the local recurrence of breast cancer. Br J Surg. 1996; 83:313-320.